Our SET-UP STRATEGIES - OPEN-SOURCE
We’re excited to announce that our innovative strategies for setting up the first multinational placebo-controlled Phase III cell therapy trial — built on a decentralized, multinational academic GMP-manufacturing network — are now publicly accessible!
This achievement marks a milestone in the advancement of cell therapy research. Our approach demonstrates how collaborative innovation, harmonized standards and academic excellence can enable complex clinical trials across borders and institutions.
Discover how we overcame regulatory, logistical and manufacturing challenges to pave the way for a new era of decentralized, coordinated cell therapy development across Europe.
Learn more about our approach and explore our clinical trial strategy as well as our manufacturing strategy here.